TOI
The Oncology·NASDAQ
--
--(--)
--
--(--)
2.48 / 10
Underperform
TOI's fundamentals are a concern, earning a 2.5/10. Key weaknesses include negative year-over-year growth in basic and diluted earnings per share, as well as total and net profit. Cash flow from operating activities shows a positive YoY growth of 9.45%, and Net income/Revenue is only slightly negative at -0.1668, providing minor relief. Asset-MV and Revenue-MV are in the lower quartiles, historically underperforming. The stock's valuation factors do not compensate for weak earnings, leading to an overall prudent stance.
Analysis Checks(3/10)
Revenue-MV
Value1.11
Score2/3
Weight12.62%
1M Return2.84%
Value1.11
Score2/3
Weight12.62%
1M Return2.84%
Net income-Revenue
Value-0.17
Score1/3
Weight12.90%
1M Return2.53%
Value-0.17
Score1/3
Weight12.90%
1M Return2.53%
Total profit (YoY growth rate %)
Value-3.40
Score1/3
Weight8.87%
1M Return1.57%
Value-3.40
Score1/3
Weight8.87%
1M Return1.57%
Diluted earnings per share (YoY growth rate %)
Value12.50
Score1/3
Weight3.07%
1M Return0.52%
Value12.50
Score1/3
Weight3.07%
1M Return0.52%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-4.03
Score1/3
Weight12.22%
1M Return2.16%
Value-4.03
Score1/3
Weight12.22%
1M Return2.16%
Net cash flow from operating activities per share (YoY growth rate %)
Value29.88
Score1/3
Weight6.79%
1M Return1.22%
Value29.88
Score1/3
Weight6.79%
1M Return1.22%
Basic earnings per share (YoY growth rate %)
Value12.50
Score1/3
Weight3.32%
1M Return0.58%
Value12.50
Score1/3
Weight3.32%
1M Return0.58%
Net cash flow from operating activities (YoY growth rate %)
Value9.45
Score2/3
Weight15.59%
1M Return2.70%
Value9.45
Score2/3
Weight15.59%
1M Return2.70%
Asset-MV
Value-0.50
Score3/3
Weight25.18%
1M Return4.29%
Value-0.50
Score3/3
Weight25.18%
1M Return4.29%
Cash-MV
Value-0.07
Score1/3
Weight-0.55%
1M Return-0.11%
Value-0.07
Score1/3
Weight-0.55%
1M Return-0.11%
Revenue-MV
Value1.11
Score2/3
Weight12.62%
1M Return2.84%
Value1.11
Score2/3
Weight12.62%
1M Return2.84%
Net cash flow from operating activities per share (YoY growth rate %)
Value29.88
Score1/3
Weight6.79%
1M Return1.22%
Value29.88
Score1/3
Weight6.79%
1M Return1.22%
Net income-Revenue
Value-0.17
Score1/3
Weight12.90%
1M Return2.53%
Value-0.17
Score1/3
Weight12.90%
1M Return2.53%
Basic earnings per share (YoY growth rate %)
Value12.50
Score1/3
Weight3.32%
1M Return0.58%
Value12.50
Score1/3
Weight3.32%
1M Return0.58%
Total profit (YoY growth rate %)
Value-3.40
Score1/3
Weight8.87%
1M Return1.57%
Value-3.40
Score1/3
Weight8.87%
1M Return1.57%
Net cash flow from operating activities (YoY growth rate %)
Value9.45
Score2/3
Weight15.59%
1M Return2.70%
Value9.45
Score2/3
Weight15.59%
1M Return2.70%
Diluted earnings per share (YoY growth rate %)
Value12.50
Score1/3
Weight3.07%
1M Return0.52%
Value12.50
Score1/3
Weight3.07%
1M Return0.52%
Asset-MV
Value-0.50
Score3/3
Weight25.18%
1M Return4.29%
Value-0.50
Score3/3
Weight25.18%
1M Return4.29%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-4.03
Score1/3
Weight12.22%
1M Return2.16%
Value-4.03
Score1/3
Weight12.22%
1M Return2.16%
Cash-MV
Value-0.07
Score1/3
Weight-0.55%
1M Return-0.11%
Value-0.07
Score1/3
Weight-0.55%
1M Return-0.11%
Is TOI undervalued or overvalued?
- TOI scores 2.48/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -14.38% net margin, -3.90 P/E ratio, -20.92 P/B ratio, and 16.88% earnings growth, these metrics solidify its Underperform investment rating.
